文献速递肝病

红景天苷激活AMPK通路抑制小鼠非酒精性脂肪性肝炎

Salidroside Activates the AMP-Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice.
PubMed 文献 · Hepatology · 2021-10-21

该研究在小鼠原代肝细胞及HFHC饮食诱导的NASH模型中评估红景天苷(SAL)的作用。SAL可减轻脂质蓄积和炎症、改善糖代谢紊乱与胰岛素抵抗并抑制纤维化,机制为激活AMPK信号通路,且AMPK阻断可消除其保护效应。

要点

  • SAL在PO刺激的原代肝细胞中减轻脂质蓄积和炎症反应。
  • SAL通过激活AMPK信号通路发挥对NASH进展的保护作用。
  • AMPK阻断可消除SAL对肝细胞和肝脏脂质蓄积与炎症的保护效应。

核心结论

  • SAL通过激活AMPK信号通路保护小鼠免受代谢应激诱导的NASH进展,可能成为NASH治疗的潜在药物成分。

研究设计与样本

  • 研究采用原代肝细胞经棕榈酸/油酸(PO)刺激的体外模型,以及高脂/高胆固醇(HFHC)饮食诱导的小鼠NASH模型。

主要发现

  • SAL减轻PO刺激的原代肝细胞中的脂质蓄积和炎症反应。
  • SAL有效预防HFHC饮食诱导的NASH进展,调控糖代谢紊乱、胰岛素抵抗、脂质蓄积、炎症和纤维化。
  • 整合RNA测序和生物信息学分析显示SAL在体外和体内促进AMPK信号通路激活,并经AMPK磷酸化水平测定验证。
  • AMPK阻断可消除SAL对PO或HFHC刺激所致肝细胞和肝脏脂质蓄积与炎症的保护作用。

临床怎么用

  • 本研究为动物与细胞实验,SAL尚未在临床NASH患者中验证,不能直接用于临床用药决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: NASH is becoming a leading cause of liver cirrhosis and HCC. Salidroside (p-hydroxyphenethyl-β-D-glucoside; SAL) has various biological and pharmacological activities, including anti-inflammatory, -oxidant, and -cancer activities. However, the therapeutic effect and underlying molecular mechanism of SAL in NASH remain to be further clarified. METHODS AND RESULTS: In this study, we found that SAL alleviated lipid accumulation and inflammatory response in primary hepatocytes after palmitic acid/oleic acid (PO) stimulation. In addition, SAL effectively prevented high-fat/high-cholesterol (HFHC)-diet-induced NASH progression by regulating glucose metabolism dysregulation, insulin resistance, lipid accumulation, inflammation, and fibrosis. Mechanistically, integrated RNA-sequencing and bioinformatic analysis showed that SAL promoted AMPK-signaling pathway activation in vitro and in vivo, and this finding was further verified by determining the phosphorylation levels of AMPK. Furthermore, the protective effects of SAL on lipid accumulation and inflammation in hepatocytes and livers induced by PO or HFHC stimulation were blocked by AMPK interruption. CONCLUSIONS: Our studies demonstrate that SAL protects against metabolic-stress-induced NASH progression through activation of AMPK signaling, indicating that SAL could be a potential drug component for NASH therapy.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Hu M, Zhang D, Xu H, et al. Salidroside Activates the AMP-Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice. Hepatology. 2021. PMID: 34292604. doi:10.1002/hep.32066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。